NCT00969033View on ClinicalTrials.gov

CS-1008 Used With Irinotecan Versus Irinotecan Alone in Subjects With Metastatic Colorectal Carcinoma Who Failed First-line Treatment With Oxaliplatin

PHASE2TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Metastatic Colorectal Cancer
Interventions
DRUG

CS-1008

CS-1008

DRUG

irinotecan

irinotecan

Trial Locations (9)

CM1 7ET

Broomfield Hospital, Chelmsford

HA6 2RN

Mount Vernon Hospital, Northwood

NG5 1PB

Nottingham City Hospital, Nottingham

OX37LJ

Chrichill Hospital, Oxford

SM2 5PT

Royal Marsden Hospital, Sutton

CH634JY

Clatterbridge Hospital, Bebington

BA1 3NG

Royal United Hospital Bath, Bath

DY1 2HQ

Russels Hall Hospital, Dudley

LE1 5WW

Leicester Royal Infirmary, Leicester

Sponsors

Lead Sponsor

Daiichi Sankyo
All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY

NCT00969033 - CS-1008 Used With Irinotecan Versus Irinotecan Alone in Subjects With Metastatic Colorectal Carcinoma Who Failed First-line Treatment With Oxaliplatin | Biotech Hunter | Biotech Hunter